These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1102266)

  • 1. Potent combinations of beta-lactam antibiotics using the beta-lactamase inhibition principle.
    Greenwood D; O'Grady F
    Chemotherapy; 1975; 21(6):330-41. PubMed ID: 1102266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined action of beta-lactum antibiotics against gram-negative bacilli.
    Bobrowski MM; Gebicka K; Borowski J
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(2):129-40. PubMed ID: 4199760
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance to beta-lactam antibiotics Proteus strains.
    Lachmajer-Lutoslawska M; Bobrowski M
    Acta Microbiol Pol A; 1975; 8(3):141-9. PubMed ID: 1103580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity against Escherichia coli of CGP 9000, a new oral cephalosporin.
    Greenwood D
    J Antibiot (Tokyo); 1978 Jul; 31(7):697-702. PubMed ID: 357363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Lactamases and resistance to penicillins and cephalosporins in Serratia marcescens.
    Farrar WE; O'dell NM
    J Infect Dis; 1976 Sep; 134(3):245-51. PubMed ID: 789784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative performance of beta-lactam antibiotics against ampicillin sensitive Escherichia coli in conditions simulating those of the infected urinary bladder.
    Greenwood D; O'Grady F
    Br J Exp Pathol; 1974 Jun; 55(3):245-50. PubMed ID: 4607731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
    Zhao WH; Hu ZQ; Chen G; Ito R; Shimamura T
    Chemotherapy; 2008; 54(1):31-7. PubMed ID: 18063864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the -lactamases of Escherichia coli and Klebsiella aerogenes by semi-synthetic penicillins.
    Cole M; Elson S; Fullbrook PD
    Biochem J; 1972 Mar; 127(1):295-308. PubMed ID: 4561388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vitro evaluation of clavulanic acid, a potent, broad-spectrum beta-lactamase inhibitor.
    Greenwood D; O'Grady F; Baker P
    J Antimicrob Chemother; 1979 Sep; 5(5):539-47. PubMed ID: 387706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of ampicillin resistant Escherichia coli to cephalosporins in an in vitro model simulating conditions of bacterial growth in the urinary bladder.
    Greenwood D; O'Grady F
    Br J Exp Pathol; 1975 Apr; 56(2):167-71. PubMed ID: 1106751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of penicillinase-resistant penicillins to increase the susceptibility of gram-negative bacteria to antibiotics.
    Farrar WE; O'Dell NM; Krause JM
    Ann Intern Med; 1967 Oct; 67(4):733-43. PubMed ID: 4862467
    [No Abstract]   [Full Text] [Related]  

  • 12. Resistance of penicillins and cephalosporins to beta-lactamases from Gram-negative bacilli: some correlations with antibacterial activity.
    Sabath LD; Finland M
    Ann N Y Acad Sci; 1967 Sep; 145(2):237-47. PubMed ID: 4998177
    [No Abstract]   [Full Text] [Related]  

  • 13. Enterobacteria, beta-lactam antibiotics and beta-lactamases in clinical practice.
    Newsom SW; Marshall MJ; Harris AM
    J Med Microbiol; 1974 Nov; 7(4):473-82. PubMed ID: 4615152
    [No Abstract]   [Full Text] [Related]  

  • 14. Penicillins and cephalosporins: differences in morphologic effects on Proteus mirabilis.
    Lorain V; Sabath LD
    J Infect Dis; 1972 May; 125(5):560-4. PubMed ID: 4554111
    [No Abstract]   [Full Text] [Related]  

  • 15. Laboratory studies on mecillinam: activity alone and combined with cephradine.
    Kerry DW; Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1977 Jul; 3 Suppl B():53-8. PubMed ID: 587708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of in vitro activities of eight new beta-lactam compounds against cephalothin-resistant Enterobacteriaceae from hospital patients.
    Costopoulos C; Legakis NJ; Papafragas E; Marinis E
    Chemotherapy; 1984; 30(3):158-64. PubMed ID: 6610538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the responses of Escherichia coli and proteus mirabilis to seven beta-lactam antibodies.
    Greenwood D; O'Grady F
    J Infect Dis; 1973 Aug; 128(2):211-22. PubMed ID: 4579140
    [No Abstract]   [Full Text] [Related]  

  • 18. Joint action of beta-lactam antibiotics.
    Cheung KS; Maniar AC
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):309-15. PubMed ID: 4996194
    [No Abstract]   [Full Text] [Related]  

  • 19. [Synergistic effect of ampicillin and dicloxacillin on penicillin and cephalosporin-susceptible Escherichia coli (author's transl)].
    Morohoshi T; Sagai H; Mizoguchi J; Otani M
    Jpn J Antibiot; 1978 Oct; 31(10):606-9. PubMed ID: 366193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of cephalothin and three penicillins against Escherichia coli and Proteus species.
    Barry AL; Hoeprich PD
    Antimicrob Agents Chemother; 1973 Sep; 4(3):354-60. PubMed ID: 4202343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.